Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Personalized mRNA Tumor Vaccine
The First People's Hospital of Lianyungang
Esophageal Cancer
1 trial -
Photo-responsive nanozyme
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Phytosterols & placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-alcoholic Fatty Liver Disease
1 trial -
Pitavastatin and placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Placebo
Hospital Authority, Hong Kong
Hypertension in Pregnancy
1 trial -
Placebo
Hospital Authority, Hong Kong
Chronic Kidney Disease
1 trial -
Placebo (for Motilitone)
Samsung Bioepis NL B.V.
Dyspepsia
1 trial -
Placebo 1 to Probiotic A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Dysfunction
1 trial -
Placebo plus high-intensity statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Polyethylene glycol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Polyethylene glycol (PEG)
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Postoperative radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Tongue Squamous Cell Carcinoma
1 trial -
Prebiotic Fiber Supplement + loperamide hydrochloride capsule
The First People's Hospital of Lianyungang
Chemotherapy-related Diarrhea
1 trial -
Prebiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
Prediction Model Arm
The First People's Hospital of Lianyungang
Lung Cancer Screening
1 trial -
Prediction of intraoperative hypothermia risk
The First People's Hospital of Lianyungang
Intraoperative Hypothermia
1 trial -
Prednisolone
The First People's Hospital of Lianyungang
HIV (Human Immunodeficiency Virus)
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Undifferentiated Connective Tissue Disease
1 trial -
Pregabalin capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia
1 trial -
Prepackaged Low-residue diet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colon Polyp
1 trial -
Probiotics daily
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2
1 trial -
Progesterone
Hospital Authority, Hong Kong
Preterm
1 trial -
Propofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastroscopy
1 trial -
Propofol
Hospital Authority, Hong Kong
Renal Cell Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources